Nephrology specialists Carla Nester, MD, and Andrew Bomback, MD, delve into the rare and difficult-to-diagnose disease state of C3 glomerulopathy, a membranoproliferative form of glomerulonephritis. Recent guideline updates and recommended clinical management strategies for the treatment of glomerular disease are reviewed. In addition, the specific pathophysiology, clinical features and diagnosis of C3 glomerulopathy are discussed, as well as the global patient burden of disease and concomitant disease states caused by complement dysregulation. Insight into the historical management of C3 glomerulopathy and targeted therapies currently undergoing evaluation in late clinical trials are provided. Finally, patient resources, supportive measures and clinical perspective on the future of C3 glomerulopathy management are discussed by the faculty.
This program is also available as a podcast. You may download it here: https://anchor.fm/c3-glomerulopathy
Course Credit:
1 AMA PRA Category 1 CreditTM
1 ANCC Contact Hour
1 CA-BRN Contact Hour
1 Pharmacology Hour
Dates:
Opens: 2022-12-15
Closes: 2023-12-15
Target Audience:
This activity is intended for nephrologists, nephrology physician associates/physician assistants and nurse practitioners, primary care physicians, pediatricians, surgeons who specialize in organ transplants, and other healthcare professionals who may be involved in diagnosis and treatment of patients with C3 glomerulopathy (C3G).
This activity is supported by an educational grant from Novartis.
-
Andrew S. Bomback, MD, MPH
Associate Professor of Medicine
Director of Clinical Research, Division of Nephrology
Columbia University Irving Medical Center
New York, New York -
Carla M. Nester, MD, MSA
Jean E. Robillard MD Endowed Chair in Pediatric Nephrology
Director, Division of Pediatric Nephrology, Dialysis and Transplantation
Associate Director, Molecular Otolaryngology and Renal Research Laboratory
University of Iowa Stead Family Children’s Hospital
Iowa City, Iowa
